Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) announced it will present six posters from its systems-biology derived antibody engineering and nanotherapeutic portfolios ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE